Correlation
The correlation between ELV and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
ELV vs. ABBV
Compare and contrast key facts about Elevance Health Inc (ELV) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ELV or ABBV.
Performance
ELV vs. ABBV - Performance Comparison
Loading data...
Key characteristics
ELV:
-0.79
ABBV:
0.86
ELV:
-1.07
ABBV:
1.14
ELV:
0.85
ABBV:
1.18
ELV:
-0.75
ABBV:
1.08
ELV:
-1.19
ABBV:
2.49
ELV:
21.91%
ABBV:
9.03%
ELV:
30.17%
ABBV:
28.28%
ELV:
-67.19%
ABBV:
-45.09%
ELV:
-31.56%
ABBV:
-13.53%
Fundamentals
ELV:
$85.39B
ABBV:
$328.06B
ELV:
$25.85
ABBV:
$2.34
ELV:
14.62
ABBV:
78.24
ELV:
0.68
ABBV:
0.40
ELV:
0.47
ABBV:
5.72
ELV:
2.01
ABBV:
231.03
ELV:
$183.12B
ABBV:
$57.37B
ELV:
$114.62B
ABBV:
$44.44B
ELV:
$10.09B
ABBV:
$16.36B
Returns By Period
In the year-to-date period, ELV achieves a 3.59% return, which is significantly lower than ABBV's 6.42% return. Over the past 10 years, ELV has underperformed ABBV with an annualized return of 10.00%, while ABBV has yielded a comparatively higher 15.45% annualized return.
ELV
3.59%
-8.01%
-4.73%
-23.64%
-8.77%
6.61%
10.00%
ABBV
6.42%
-4.08%
3.29%
24.28%
11.50%
19.71%
15.45%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ELV vs. ABBV — Risk-Adjusted Performance Rank
ELV
ABBV
ELV vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Elevance Health Inc (ELV) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
ELV vs. ABBV - Dividend Comparison
ELV's dividend yield for the trailing twelve months is around 1.73%, less than ABBV's 3.44% yield.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ELV Elevance Health Inc | 1.73% | 1.77% | 1.26% | 1.00% | 0.98% | 1.18% | 1.06% | 1.14% | 1.20% | 1.81% | 1.79% | 1.39% |
ABBV AbbVie Inc. | 3.44% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
ELV vs. ABBV - Drawdown Comparison
The maximum ELV drawdown since its inception was -67.19%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ELV and ABBV.
Loading data...
Volatility
ELV vs. ABBV - Volatility Comparison
Elevance Health Inc (ELV) has a higher volatility of 14.65% compared to AbbVie Inc. (ABBV) at 9.89%. This indicates that ELV's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
ELV vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Elevance Health Inc and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ELV vs. ABBV - Profitability Comparison
ELV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Elevance Health Inc reported a gross profit of 43.91B and revenue of 48.89B. Therefore, the gross margin over that period was 89.8%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
ELV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Elevance Health Inc reported an operating income of 3.14B and revenue of 48.89B, resulting in an operating margin of 6.4%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
ELV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Elevance Health Inc reported a net income of 2.18B and revenue of 48.89B, resulting in a net margin of 4.5%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.